Login

Healthcare

00:10:00
Xspray Pharma CEO Presents at Naventus Life Science Summit 2021 | PER ANDERSSON , CEO OF XSPRAY PHARMA AB
00:10:00
Xtant Medical (NYSE: XTNT) CEO Sean Browne Discusses Surging Demand and Growth Strategy Amid Successful Biologics Product Launches | SEAN BROWNE , CEO OF XTANT MEDICAL HOLDINGS INC
00:10:00
Life Science Capital Strategies in Challenging Markets | Jonathan Gertler, CEO of Back Bay life science advisors
00:10:00
Ovation Science Inc. CEO Terry Howlett Talks Innovations in CBD/THC Products and Invisicare® Skin Delivery Technology| TERRY HOWLETT , CEO OF OVATION SCIENCE, INC
00:10:00
Gain Therapeutics and Zentalis Pharmaceuticals Forge Innovative Partnership in Multi-Target Oncology Drug Discovery and Development | KIMBERLY BLACKWELL, MD , CHIEF EXECUTIVE OFFICER OF ZENTALIS PHARMACEUTICALS INC
00:10:00
Unveiling Innovation at Zentiva's Cutting-Edge R&D Center: Pioneering Pharmaceutical Breakthroughs for a Healthier Tomorrow | STEFFEN SALTOFTE , CHIEF EXECUTIVE OFFICER OF ZENTIVA SA
00:10:00
Taking Care of Present Issues While Gazing Forward | NICHOLAS GREEN, CEO, AVID BIOSERVICES INC
00:10:00
Generating immune cells from induced pluripotent stem cells to combat a variety of malignancies | MR. CHOO CHEE KONG, CHAIRMAN AND DIRECTOR, CYTOMED THERAPEUTICS
00:10:00
Zymeworks CEO Ali Tehrani on Biotech Success and Challenges | ALI TEHRANI, PH.D. , PRESIDENT & CHIEF EXECUTIVE OFFICER OF ZYMEWORKS INC
00:10:00
Zynerba Pharmaceuticals Bolsters IP Portfolio for Zygel, Revolutionary Cannabidiol Clear Gel with Enhanced Transdermal Delivery| ARMANDO ANIDO , CHAIRMAN OF THE BOARD AND CHIEF EXECUTIVE OFFICER OF ZYNERBA PHARMACEUTICALS, INC
00:10:00
ZyVersa Therapeutics Pioneer Breakthroughs in Inflammatory and Kidney Disease Treatment | STEPHEN C. GLOVER , CO-FOUNDER, CHIEF EXECU TIVE OFFICER, AND CHAIRMAN OF ZYVERSA THERAPEUTICS INC
00:10:00
Navigating Complex Pipelines and Scalable Manufacturing Platforms| ALESSANDRO MASELLI , CHIEF EXECUTIVE OFFICER OF CATALENT
00:10:00
Biogen CEO on Revolutionizing Drug Development for Rare Diseases with n-Lorem | CHRISTOPHER A. VIEHBACHER, PRESIDENT AND CHIEF EXECUTIVE OFFICER OF BIOGEN
00:10:00
Neurosciences Avidity - Myotonic Dystrophy | SARAH BOYCE, PRESIDENT & CHIEF EXECUTIVE, FICER OF AVIDITY BIOSCIENCES INC
00:10:00
Global Commerce with Kathy Ireland®-Advances in Incontinence Management with Dr. Karen Noblett | Raymond W. Cohen, CHIEF EXECUTIVE OFFICER, AXONICS INC
00:10:00
Clarivate assists clients in finding, safeguarding, and promoting their inventions | JONATHAN GEAR, CEO, Clarivate PLC

© 2017 - Townhall + Tv